108 related articles for article (PubMed ID: 3479296)
1. Relative bioavailability of ofloxacin tablets in comparison to oral solution.
Malerczyk V; Verho M; Korn A; Rangoonwala R
Curr Med Res Opin; 1987; 10(8):514-20. PubMed ID: 3479296
[TBL] [Abstract][Full Text] [Related]
2. Dose linearity and other pharmacokinetics of ofloxacin: a new, broad-spectrum antimicrobial agent.
Verho M; Malerczyk V; Dagrosa E; Korn A
Pharmatherapeutica; 1985; 4(6):376-82. PubMed ID: 3866256
[TBL] [Abstract][Full Text] [Related]
3. The effect of food on the pharmacokinetics of ofloxacin.
Verho M; Malerczyk V; Dagrosa E; Korn A
Curr Med Res Opin; 1986; 10(3):166-71. PubMed ID: 3460737
[TBL] [Abstract][Full Text] [Related]
4. The bioavailability of ofloxacin from several formulations.
Flor S; Beals B
Curr Med Res Opin; 1991; 12(5):282-6. PubMed ID: 2004540
[TBL] [Abstract][Full Text] [Related]
5. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.
Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K
Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701
[TBL] [Abstract][Full Text] [Related]
6. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and relative bioavailability of ofloxacin tablets in 12 healthy volunteers.
Diao Y; Li L; Zhou GH; Cheng Y
Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):110-2. PubMed ID: 1598824
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of levofloxacin in comparison to the racemic mixture of ofloxacin in man.
Verho M; Malerczyk V; Damm D; Lehr KH
Drug Metabol Drug Interact; 1996; 13(1):57-67. PubMed ID: 8902431
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence study of a fixed dose combination of nitazoxanide and ofloxacin in Indian healthy volunteers.
Agarwal S; Solomon WD; Gowda KV; Selvan PS; Ghosh D; Sarkar AK; Chattaraj TK; Pal TK
Arzneimittelforschung; 2007; 57(10):679-83. PubMed ID: 18074762
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability and pharmacokinetics of oral ofloxacin formulations in normal subjects.
Stein GE; LeBel M; Flor SC; Zinny M
Curr Med Res Opin; 1991; 12(8):479-84. PubMed ID: 1764952
[TBL] [Abstract][Full Text] [Related]
11. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
[TBL] [Abstract][Full Text] [Related]
12. The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects.
Vincent J; Teng R; Pelletier SM; Willavize SA; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):23S-26S. PubMed ID: 9935253
[TBL] [Abstract][Full Text] [Related]
13. [Absorption, distribution, metabolism and excretion of T-3761, a new quinolone derivative, in experimental animals].
Minami S; Takahata M; Hayashi T; Kumano K; Ikeda Y; Noumi T; Takagi S; Oogake N; Tsuneda R; Maehana J
Jpn J Antibiot; 1995 May; 48(5):626-42. PubMed ID: 7637197
[TBL] [Abstract][Full Text] [Related]
14. Dose linearity testing of intravenous ofloxacin, a novel gyrase inhibitor.
Verho M; Korn A; Badian M; Malerczyk V; Waldhäusl W
Chemotherapy; 1988; 34(3):170-7. PubMed ID: 3166420
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability of different formulations of levothyroxine and liothyronine in healthy volunteers.
Leggio GM; Incognito T; Privitera G; Marano MR; Drago F
J Endocrinol Invest; 2006 Dec; 29(11):RC35-8. PubMed ID: 17259789
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
17. The clinical pharmacokinetics of levofloxacin.
Fish DN; Chow AT
Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
[TBL] [Abstract][Full Text] [Related]
18. [Transfer of ofloxacin into suction blister fluid after its oral administration].
Aoyama H; Sugiyama H; Ishii T; Kawauchi T; Kasuya T; Nishizaki A; Okuda J
Jpn J Antibiot; 1987 Nov; 40(11):1937-40. PubMed ID: 3481837
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of ofloxacin after parenteral and oral administration.
Lode H; Höffken G; Olschewski P; Sievers B; Kirch A; Borner K; Koeppe P
Antimicrob Agents Chemother; 1987 Sep; 31(9):1338-42. PubMed ID: 3479046
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
